Methods for DNA methylation analysis and applications in colon cancer

Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis

Volumn 693, Issue 1-2, 2010, Pages 84-93

  Jordà, Mireia ^a   Peinado, Miguel A ^a  

^a Institut de Medicina Predictiva i Personalitzada del Cancer IMPPC   (Spain)

Author keywords

5 Methyltcytosine; Clinical marker; Colorectal cancer; DNA methylation methods

Indexed keywords

CANCER RESEARCH; CAPILLARY ELECTROPHORESIS; CARCINOGENESIS; COLON CANCER; COLON POLYPOSIS; CPG ISLAND; DNA DENATURATION; DNA FINGERPRINTING; DNA METHYLATION; DNA MICROARRAY; EPIGENETICS; GENETIC ANALYSIS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROCESS OPTIMIZATION; PYROSEQUENCING; RESTRICTION MAPPING; REVIEW;

COLONIC NEOPLASMS; DNA METHYLATION; DNA, NEOPLASM; EPIGENOMICS; GENETIC MARKERS; HUMANS;

MAMMALIA;

EID: 78049443508     PISSN: 00275107     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mrfmmm.2010.06.010     Document Type: Review

References (115)

1. Lander E.S., Linton L.M., Birren B., Nusbaum C., Zody M.C., Baldwin J., Devon K., Dewar K., Doyle M., FitzHugh W., Funke R., Gage D., Harris K., Heaford A., Howland J., Kann L., Lehoczky J., LeVine R., McEwan P., McKernan K., Meldrim J., Mesirov J.P., Miranda C., Morris W., Naylor J., Raymond C., Rosetti M., Santos R., Sheridan A., Sougnez C., Stange-Thomann N., Stojanovic N., Subramanian A., Wyman D., Rogers J., Sulston J., Ainscough R., Beck S., Bentley D., Burton J., Clee C., Carter N., Coulson A., Deadman R., Deloukas P., Dunham A., Dunham I., Durbin R., French L., Grafham D., Gregory S., Hubbard T., Humphray S., Hunt A., Jones M., Lloyd C., McMurray A., Matthews L., Mercer S., Milne S., Mullikin J.C., Mungall A., Plumb R., Ross M., Shownkeen R., Sims S., Waterston R.H., Wilson R.K., Hillier L.W., McPherson J.D., Marra M.A., Mardis E.R., Fulton L.A., Chinwalla A.T., Pepin K.H., Gish W.R., Chissoe S.L., Wendl M.C., Delehaunty K.D., Miner T.L., Delehaunty A., Kramer J.B., Cook L.L., Fulton R.S., Johnson D.L., Minx P.J., Clifton S.W., Hawkins T., Branscomb E., Predki P., Richardson P., Wenning S., Slezak T., Doggett N., Cheng J.F., Olsen A., Lucas S., Elkin C., Uberbacher E., Frazier M., Gibbs R.A., Muzny D.M., Scherer S.E., Bouck J.B., Sodergren E.J., Worley K.C., Rives C.M., Gorrell J.H., Metzker M.L., Naylor S.L., Kucherlapati R.S., Nelson D.L., Weinstock G.M., Sakaki Y., Fujiyama A., Hattori M., Yada T., Toyoda A., Itoh T., Kawagoe C., Watanabe H., Totoki Y., Taylor T., Weissenbach J., Heilig R., Saurin W., Artiguenave F., Brottier P., Bruls T., Pelletier E., Robert C., Wincker P., Smith D.R., Doucette-Stamm L., Rubenfield M., Weinstock K., Lee H.M., Dubois J., Rosenthal A., Platzer M., Nyakatura G., Taudien S., Rump A., Yang H., Yu J., Wang J., Huang G., Gu J., Hood L., Rowen L., Madan A., Qin S., Davis R.W., Federspiel N.A., Abola A.P., Proctor M.J., Myers R.M., Schmutz J., Dickson M., Grimwood J., Cox D.R., Olson M.V., Kaul R., Shimizu N., Kawasaki K., Minoshima S., Evans G.A., Athanasiou M., Schultz R., Roe B.A., Chen F., Pan H., Ramser J., Lehrach H., Reinhardt R., McCombie W.R., de la Bastide M., Dedhia N., Blocker H., Hornischer K., Nordsiek G., Agarwala R., Aravind L., Bailey J.A., Bateman A., Batzoglou S., Birney E., Bork P., Brown D.G., Burge C.B., Cerutti L., Chen H.C., Church D., Clamp M., Copley R.R., Doerks T., Eddy S.R., Eichler E.E., Furey T.S., Galagan J., Gilbert J.G., Harmon C., Hayashizaki Y., Haussler D., Hermjakob H., Hokamp K., Jang W., Johnson L.S., Jones T.A., Kasif S., Kaspryzk A., Kennedy S., Kent W.J., Kitts P., Koonin E.V., Korf I., Kulp D., Lancet D., Lowe T.M., McLysaght A., Mikkelsen T., Moran J.V., Mulder N., Pollara V.J., Ponting C.P., Schuler G., Schultz J., Slater G., Smit A.F., Stupka E., Szustakowski J., Thierry-Mieg D., Thierry-Mieg J., Wagner L., Wallis J., Wheeler R., Williams A., Wolf Y.I., Wolfe K.H., Yang S.P., Yeh R.F., Collins F., Guyer M.S., Peterson J., Felsenfeld A., Wetterstrand K.A., Patrinos A., Morgan M.J., de Jong P., Catanese J.J., Osoegawa K., Shizuya H., Choi S., Chen Y.J. Initial sequencing and analysis of the human genome. Nature 2001, 409:860-921.
2. Bird A. DNA methylation patterns and epigenetic memory. Genes Dev. 2002, 16:6-21.
3. Jones P.A., Baylin S.B. The fundamental role of epigenetic events in cancer. Nat. Rev. Genet. 2002, 3:415-428.
4. Herman J.G., Baylin S.B. Gene silencing in cancer in association with promoter hypermethylation. N. Engl. J. Med. 2003, 349:2042-2054.
5. Bird A.P. CpG-rich islands and the function of DNA methylation. Nature 1986, 321:209-213.
6. Ramsahoye B.H., Biniszkiewicz D., Lyko F., Clark V., Bird A.P., Jaenisch R. Non-CpG methylation is prevalent in embryonic stem cells and may be mediated by DNA methyltransferase 3a. Proc. Natl. Acad. Sci. U. S. A. 2000, 97:5237-5242.
7. Sved J., Bird A. The expected equilibrium of the CpG dinucleotide in vertebrate genomes under a mutation model. Proc. Natl. Acad. Sci. U. S. A. 1990, 87:4692-4696.
8. Chan M.F., van Amerongen R., Nijjar T., Cuppen E., Jones P.A., Laird P.W. Reduced rates of gene loss, gene silencing, and gene mutation in Dnmt1-deficient embryonic stem cells. Mol. Cell. Biol. 2001, 21:7587-7600.
9. Gardiner-Garden M, Frommer M. CpG islands in vertebrate genomes. J. Mol. Biol. 1987, 196:261-282.
10. Takai D., Jones P.A. Comprehensive analysis of CpG islands in human chromosomes 21 and 22. Proc. Natl. Acad. Sci. U. S. A. 2002, 99:3740-3745.
11. Goll M.G., Bestor T.H. Eukaryotic cytosine methyltransferases. Annu. Rev. Biochem. 2005, 74:481-514.
12. Yoder J.A., Walsh C.P., Bestor T.H. Cytosine methylation and the ecology of intragenomic parasites. Trends Genet. 1997, 13:335-340.
13. Eden A., Gaudet F., Waghmare A., Jaenisch R. Chromosomal instability and tumors promoted by DNA hypomethylation. Science 2003, 300:455.
14. Rodriguez J., Frigola J., Vendrell E., Risques R.A., Fraga M.F., Morales C., Moreno V., Esteller M., Capella G., Ribas M., Peinado M.A. Chromosomal instability correlates with genome-wide DNA demethylation in human primary colorectal cancers. Cancer Res. 2006, 66:8462-9468.
15. Iguchi-Ariga S.M., Schaffner W. CpG methylation of the cAMP-responsive enhancer/promoter sequence TGACGTCA abolishes specific factor binding as well as transcriptional activation. Genes Dev. 1989, 3:612-619.
16. Molloy P.L., Watt F. DNA methylation and specific protein-DNA interactions. Philos. Trans. R. Soc. Lond. B: Biol. Sci. 1990, 326:267-275.
17. Nan X., Ng H.H., Johnson C.A., Laherty C.D., Turner B.M., Eisenman R.N., Bird A. Transcriptional repression by the methyl-CpG-binding protein MeCP2 involves a histone deacetylase complex. Nature 1998, 393:386-389.
18. Bird A.P., Wolffe A.P. Methylation-induced repression-belts, braces, and chromatin. Cell 1999, 99:451-454.
19. Rollins R.A, Haghighi F., Edwards J.R., Das R., Zhang M.Q., Ju J., Bestor T.H. Large-scale structure of genomic methylation patterns. Genome Res. 2006, 16:157-163.
20. Ahuja N., Li Q., Mohan A.L., Baylin S.B., Issa J.P. Aging and DNA methylation in colorectal mucosa and cancer. Cancer Res. 1998, 58:5489-5494.
21. Issa J.P., Ottaviano Y.L., Celano P., Hamilton S.R., Davidson N.E., Baylin S.B. Methylation of the oestrogen receptor CpG island links ageing and neoplasia in human colon. Nat. Genet. 1994, 7:536-540.
22. Hoal-van Helden E.G., van Helden P.D. Age-related methylation changes in DNA may reflect the proliferative potential of organs. Mutat. Res. 1989, 219:263-266.
23. Gama-Sosa M.A., Slagel V.A., Trewyn R.W., Oxenhandler R., Kuo K.C., Gehrke C.W., Ehrlich M. The 5-methylcytosine content of DNA from human tumors. Nucleic Acids Res. 1983, 11:6883-6894.
24. Jones P.A., Laird P.W. Cancer epigenetics comes of age. Nat. Genet. 1999, 21:163-167.
25. Feinberg A.P., Vogelstein B. Hypomethylation distinguishes genes of some human cancers from their normal counterparts. Nature 1983, 301:89-92.
26. Lapeyre J.N., Becker F.F. 5-Methylcytosine content of nuclear DNA during chemical hepatocarcinogenesis and in carcinomas which result. Biochem. Biophys. Res. Commun. 1979, 87:698-705.
27. Weisenberger D.J., Campan M., Long T.I., Kim M., Woods C., Fiala E., Ehrlich M., Laird P.W. Analysis of repetitive element DNA methylation by MethyLight. Nucleic Acids Res. 2005, 33:6823-6836. Print 2005.
28. Narayan A., Ji W., Zhang X.Y., Marrogi A., Graff J.R., Baylin S.B., Ehrlich M. Hypomethylation of pericentromeric DNA in breast adenocarcinomas. Int. J. Cancer 1998, 77:833-838.
29. Greger V., Passarge E., Hopping W., Messmer E., Horsthemke B. Epigenetic changes may contribute to the formation and spontaneous regression of retinoblastoma. Hum. Genet. 1989, 83:155-158.
30. Herman J.G., Latif F., Weng Y., Lerman M.I., Zbar B., Liu S., Samid D., Duan D.S., Gnarra J.R., Linehan W.M., et al. Silencing of the VHL tumor-suppressor gene by DNA methylation in renal carcinoma. Proc. Natl. Acad. Sci. U. S. A. 1994, 91:9700-9704.
31. Herman J.G., Merlo A., Mao L., Lapidus R.G., Issa J.P., Davidson N.E., Sidransky D., Baylin S.B. Inactivation of the CDKN2/p16/MTS1 gene is frequently associated with aberrant DNA methylation in all common human cancers. Cancer Res. 1995, 55:4525-4530.
32. Esteller M., Sparks A., Toyota M., Sanchez-Cespedes M., Capella G., Peinado M.A., Gonzalez S., Tarafa G., Sidransky D., Meltzer S.J., Baylin S.B., Herman J.G. Analysis of adenomatous polyposis coli promoter hypermethylation in human cancer. Cancer Res. 2000, 60:4366-4371.
33. Lujambio A., Ropero S., Ballestar E., Fraga M.F., Cerrato C., Setien F., Casado S., Suarez-Gauthier A., Sanchez-Cespedes M., Git A., Spiteri I., Das P.P., Caldas C., Miska E., Esteller M. Genetic unmasking of an epigenetically silenced microRNA in human cancer cells. Cancer Res. 2007, 67:1424-1429.
34. Vogelstein B., Fearon E.R., Hamilton S.R., Kern S.E., Preisinger A.C., Leppert M., Nakamura Y., White R., Smits A.M., Bos J.L. Genetic alterations during colorectal-tumor development. N. Engl. J. Med. 1988, 319:525-532.
35. Kinzler K.W., Vogelstein B. Lessons from hereditary colorectal cancer. Cell 1996, 87:159-170.
36. Fraga M.F., Esteller M. DNA methylation: a profile of methods and applications. Biotechniques 2002, 33:632. 634, 636-649.
37. Esteller M. Cancer epigenomics: DNA methylomes and histone-modification maps. Nat. Rev. Genet. 2007, 8:286-298.
38. Zilberman D. The human promoter methylome. Nat. Genet. 2007, 39:442-443.
39. Eick D., Fritz H.J., Doerfler W. Quantitative determination of 5-methylcytosine in DNA by reverse-phase high-performance liquid chromatography. Anal. Biochem. 1983, 135:165-171.
40. Catania J., Keenan B.C., Margison G.P., Fairweather D.S. Determination of 5-methylcytosine by acid hydrolysis of DNA with hydrofluoric acid. Anal. Biochem. 1987, 167:347-351.
41. Ehrlich M., Gama-Sosa M.A., Huang L.H., Midgett R.M., Kuo K.C., McCune R.A., Gehrke C. Amount and distribution of 5-methylcytosine in human DNA from different types of tissues of cells. Nucleic Acids Res. 1982, 10:2709-2721.
42. Fraga M.F., Rodriguez R., Canal M.J. Rapid quantification of DNA methylation by high performance capillary electrophoresis. Electrophoresis 2000, 21:2990-2994.
43. Cedar H., Solage A., Glaser G., Razin A. Direct detection of methylated cytosine in DNA by use of the restriction enzyme MspI. Nucleic Acids Res. 1979, 6:2125-2132.
44. Gounari F., Banks G.R., Khazaie K., Jeggo P.A., Holliday R. Gene reactivation: a tool for the isolation of mammalian DNA methylation mutants. Genes Dev. 1987, 1:899-912.
45. Kutueva L.I., Ashapkin V.V., Vanyushin B.F. The methylation pattern of a cytosine DNA-methyltransferase gene in Arabidopsis thaliana plants. Biochem. Mol. Biol. Int. 1996, 40:347-353.
46. Frommer M., McDonald L.E., Millar D.S., Collis C.M., Watt F., Grigg G.W., Molloy P.L., Paul C.L. A genomic sequencing protocol that yields a positive display of 5-methylcytosine residues in individual DNA strands. Proc. Natl. Acad. Sci. U. S. A. 1992, 89:1827-1831.
47. Clark S.J., Harrison J., Paul C.L., Frommer M. High sensitivity mapping of methylated cytosines. Nucleic Acids Res. 1994, 22:2990-2997.
48. Shapiro R., DiFate V., Welcher M. Deamination of cytosine derivatives by bisulfite. Mechanism of the reaction. J. Am. Chem. Soc. 1974, 96:906-912.
49. Rein T., Zorbas H., DePamphilis M.L. Active mammalian replication origins are associated with a high-density cluster of mCpG dinucleotides. Mol. Cell. Biol. 1997, 17:416-426.
50. Clark S.J., Statham A., Stirzaker C., Molloy P.L., Frommer M. DNA methylation: bisulphite modification and analysis. Nat. Protoc. 2006, 1:2353-2364.
51. Ronaghi M., Uhlen M., Nyren P. A sequencing method based on real-time pyrophosphate. Science 1998, 281:363, 365.
52. Uhlmann K., Brinckmann A., Toliat M.R., Ritter H., Nurnberg P. Evaluation of a potential epigenetic biomarker by quantitative methyl-single nucleotide polymorphism analysis. Electrophoresis 2002, 23:4072-4079.
53. Herman J.G., Graff J.R., Myohanen S., Nelkin B.D., Baylin S.B. Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. Proc. Natl. Acad. Sci. U. S. A. 1996, 93:9821-9826.
54. Eads C.A., Danenberg K.D., Kawakami K., Saltz L.B., Blake C., Shibata D., Danenberg P.V., Laird P.W. MethyLight: a high-throughput assay to measure DNA methylation. Nucleic Acids Res. 2000, 28:E32.
55. Rand K.N., Ho T., Qu W., Mitchell S.M., White R., Clark S.J., Molloy P.L. Headloop suppression PCR and its application to selective amplification of methylated DNA sequences. Nucleic Acids Res. 2005, 33:e127.
56. Worm J., Aggerholm A., Guldberg P. In-tube DNA methylation profiling by fluorescence melting curve analysis. Clin. Chem. 2001, 47:1183-1189.
57. Xiong Z., Laird P.W. COBRA: a sensitive and quantitative DNA methylation assay. Nucleic Acids Res. 1997, 25:2532-2534.
58. Ehrich M., Nelson M.R., Stanssens P., Zabeau M., Liloglou T., Xinarianos G., Cantor C.R., Field J.K., van den Boom D. Quantitative high-throughput analysis of DNA methylation patterns by base-specific cleavage and mass spectrometry. Proc. Natl. Acad. Sci. U. S. A. 2005, 102:15785-15790.
59. Schatz P., Dietrich D., Schuster M. Rapid analysis of CpG methylation patterns using RNase T1 cleavage and MALDI-TOF. Nucleic Acids Res. 2004, 32:e167.
60. Gut I.G. DNA analysis by MALDI-TOF mass spectrometry. Hum. Mutat. 2004, 23:437-441.
61. Hatada I., Hayashizaki Y., Hirotsune S., Komatsubara H., Mukai T. A genomic scanning method for higher organisms using restriction sites as landmarks. Proc. Natl. Acad. Sci. U. S. A. 1991, 88:9523-9527.
62. Toyota M., Ho C., Ahuja N., Jair K.W., Li Q., Ohe-Toyota M., Baylin S.B., Issa J.P. Identification of differentially methylated sequences in colorectal cancer by methylated CpG island amplification. Cancer Res. 1999, 59:2307-2312.
63. Lisitsyn N., Wigler M. Cloning the differences between two complex genomes. Science 1993, 259:946-951.
64. Estecio M.R., Yan P.S., Ibrahim A.E., Tellez C.S., Shen L., Huang T.H., Issa J.P. High-throughput methylation profiling by MCA coupled to CpG island microarray. Genome Res. 2007, 17:1529-1536.
65. Frigola J., Ribas M., Risques R.A., Peinado M.A. Methylome profiling of cancer cells by amplification of inter-methylated sites (AIMS). Nucleic Acids Res. 2002, 30:e28.
66. Rodriguez J., Vives L., Jorda M., Morales C., Munoz M., Vendrell E., Peinado M.A. Genome-wide tracking of unmethylated DNA Alu repeats in normal and cancer cells. Nucleic Acids Res. 2008, 36:770-784.
67. Cross S.H., Charlton J.A., Nan X., Bird A.P. Purification of CpG islands using a methylated DNA binding column. Nat. Genet. 1994, 6:236-244.
68. Shiraishi M., Chuu Y.H., Sekiya T. Isolation of DNA fragments associated with methylated CpG islands in human adenocarcinomas of the lung using a methylated DNA binding column and denaturing gradient gel electrophoresis. Proc. Natl. Acad. Sci. U. S. A. 1999, 96:2913-2918.
69. Huang T.H., Perry M.R., Laux D.E. Methylation profiling of CpG islands in human breast cancer cells. Hum. Mol. Genet. 1999, 8:459-470.
70. Yan P.S., Perry M.R., Laux D.E., Asare A.L., Caldwell C.W., Huang T.H. CpG island arrays: an application toward deciphering epigenetic signatures of breast cancer. Clin. Cancer Res. 2000, 6:1432-1438.
71. Nouzova M., Holtan N., Oshiro M.M., Isett R.B., Munoz-Rodriguez J.L., List A.F., Narro M.L., Miller S.J., Merchant N.C., Futscher B.W. Epigenomic changes during leukemia cell differentiation: analysis of histone acetylation and cytosine methylation using CpG island microarrays. J. Pharmacol. Exp. Ther. 2004, 311:968-981.
72. Gitan R.S., Shi H., Chen C.M., Yan P.S., Huang T.H. Methylation-specific oligonucleotide microarray: a new potential for high-throughput methylation analysis. Genome Res. 2002, 12:158-164.
73. Lopez-Serra L., Ballestar E., Fraga M.F., Alaminos M., Setien F., Esteller M. A profile of methyl-CpG binding domain protein occupancy of hypermethylated promoter CpG islands of tumor suppressor genes in human cancer. Cancer Res. 2006, 66:8342-8346.
74. Ballestar E., Paz M.F., Valle L., Wei S., Fraga M.F., Espada J., Cigudosa J.C., Huang T.H., Esteller M. Methyl-CpG binding proteins identify novel sites of epigenetic inactivation in human cancer. EMBO J. 2003, 22:6335-6345.
75. Weber M., Davies J.J., Wittig D., Oakeley E.J., Haase M., Lam W.L., Schubeler D. Chromosome-wide and promoter-specific analyses identify sites of differential DNA methylation in normal and transformed human cells. Nat. Genet. 2005, 37:853-862.
76. Suzuki H., Gabrielson E., Chen W., Anbazhagan R., van Engeland M., Weijenberg M.P., Herman J.G., Baylin S.B. A genomic screen for genes upregulated by demethylation and histone deacetylase inhibition in human colorectal cancer. Nat. Genet. 2002, 31:141-149.
77. Bentley D.R. Whole-genome re-sequencing. Curr. Opin. Genet. Dev. 2006, 16:545-552.
78. Margulies M., Egholm M., Altman W.E., Attiya S., Bader J.S., Bemben L.A., Berka J., Braverman M.S., Chen Y.J., Chen Z., Dewell S.B., Du L., Fierro J.M., Gomes X.V., Godwin B.C., He W., Helgesen S., Ho C.H., Irzyk G.P., Jando S.C., Alenquer M.L., Jarvie T.P., Jirage K.B., Kim J.B., Knight J.R., Lanza J.R., Leamon J.H., Lefkowitz S.M., Lei M., Li J., Lohman K.L., Lu H., Makhijani V.B., McDade K.E., McKenna M.P., Myers E.W., Nickerson E., Nobile J.R., Plant R., Puc B.P., Ronan M.T., Roth G.T., Sarkis G.J., Simons J.F., Simpson J.W., Srinivasan M., Tartaro K.R., Tomasz A., Vogt K.A., Volkmer G.A., Wang S.H., Wang Y., Weiner M.P., Yu P., Begley R.F., Rothberg J.M. Genome sequencing in microfabricated high-density picolitre reactors. Nature 2005, 437:376-380.
79. Lister R., Pelizzola M., Dowen R.H., Hawkins R.D., Hon G., Tonti-Filippini J., Nery J.R., Lee L., Ye Z., Ngo Q.M., Edsall L., Antosiewicz-Bourget J., Stewart R., Ruotti V., Millar A.H., Thomson J.A., Ren B., Ecker J.R. Human DNA methylomes at base resolution show widespread epigenomic differences. Nature 2009, 462:315-322.
80. L. Laurent, E. Wong, G. Li, T. Huynh, A. Tsirigos, C.T. Ong, H.M. Low, K.W. Kin Sung, I. Rigoutsos, J. Loring, C.L. Wei, Dynamic changes in the human methylome during differentiation, Genome Res. 20 (2010) 320-331.
81. Korshunova Y., Maloney R.K., Lakey N., Citek R.W., Bacher B., Budiman A., Ordway J.M., McCombie W.R., Leon J., Jeddeloh J.A., McPherson J.D. Massively parallel bisulphite pyrosequencing reveals the molecular complexity of breast cancer-associated cytosine-methylation patterns obtained from tissue and serum DNA. Genome Res. 2008, 18:19-29.
82. Pomraning K.R., Smith K.M., Freitag M. Genome-wide high throughput analysis of DNA methylation in eukaryotes. Methods 2008.
83. Down T.A., Rakyan V.K., Turner D.J., Flicek P., Li H., Kulesha E., Graf S., Johnson N., Herrero J., Tomazou E.M., Thorne N.P., Backdahl L., Herberth M., Howe K.L., Jackson D.K., Miretti M.M., Marioni J.C., Birney E., Hubbard T.J., Durbin R., Tavare S., Beck S. A Bayesian deconvolution strategy for immunoprecipitation-based DNA methylome analysis. Nat. Biotechnol. 2008, 26:779-785.
84. Costello J.F., Fruhwald M.C., Smiraglia D.J., Rush L.J., Robertson G.P., Gao X., Wright F.A., Feramisco J.D., Peltomaki P., Lang J.C., Schuller D.E., Yu L., Bloomfield C.D., Caligiuri M.A., Yates A., Nishikawa R., Su Huang H., Petrelli N.J., Zhang X., O'Dorisio M.S., Held W.A., Cavenee W.K., Plass C. Aberrant CpG-island methylation has non-random and tumour-type-specific patterns. Nat. Genet. 2000, 24:132-138.
85. Esteller M., Corn P.G., Baylin S.B., Herman J.G. A gene hypermethylation profile of human cancer. Cancer Res. 2001, 61:3225-3229.
86. Esteller M., Toyota M., Sanchez-Cespedes M., Capella G., Peinado M.A., Watkins D.N., Issa J.P., Sidransky D., Baylin S.B., Herman J.G. Inactivation of the DNA repair gene O6-methylguanine-DNA methyltransferase by promoter hypermethylation is associated with G to A mutations in K-ras in colorectal tumorigenesis. Cancer Res. 2000, 60:2368-2371.
87. Kane M.F., Loda M., Gaida G.M., Lipman J., Mishra R., Goldman H., Jessup J.M., Kolodner R. Methylation of the hMLH1 promoter correlates with lack of expression of hMLH1 in sporadic colon tumors and mismatch repair-defective human tumor cell lines. Cancer Res. 1997, 57:808-811.
88. Nakamura N., Takenaga K. Hypomethylation of the metastasis-associated S100A4 gene correlates with gene activation in human colon adenocarcinoma cell lines. Clin. Exp. Metastasis 1998, 16:471-479.
89. Frigola J., Sole X., Paz M.F., Moreno V., Esteller M., Capella G., Peinado M.A. Differential DNA hypermethylation and hypomethylation signatures in colorectal cancer. Hum. Mol. Genet. 2005, 14:319-326.
90. Ogino S., Nosho K., Kirkner G.J., Kawasaki T., Chan A.T., Schernhammer E.S., Giovannucci E.L., Fuchs C.S. A cohort study of tumoral LINE-1 hypomethylation and prognosis in colon cancer. J. Natl. Cancer Inst. 2008, 100:1734-1738.
91. Palmisano W.A., Divine K.K., Saccomanno G., Gilliland F.D., Baylin S.B., Herman J.G., Belinsky S.A. Predicting lung cancer by detecting aberrant promoter methylation in sputum. Cancer Res. 2000, 60:5954-5958.
92. Cairns P., Esteller M., Herman J.G., Schoenberg M., Jeronimo C., Sanchez-Cespedes M., Chow N.H., Grasso M., Wu L., Westra W.B., Sidransky D. Molecular detection of prostate cancer in urine by GSTP1 hypermethylation. Clin. Cancer Res. 2001, 7:2727-2730.
93. Karpf A.R., Jones D.A. Reactivating the expression of methylation silenced genes in human cancer. Oncogene 2002, 21:5496-5503.
94. Jacinto F.V., Ballestar E., Ropero S., Esteller M. Discovery of epigenetically silenced genes by methylated DNA immunoprecipitation in colon cancer cells. Cancer Res. 2007, 67:11481-11486.
95. Frigola J., Muñoz M., Clark S.J., Moreno V., Capella G., Peinado M.A. Hypermethylation of the prostacyclin synthase (PTGIS) promoter is a frequent event in colorectal cancer and associated with aneuploidy. Oncogene 2005, 24:7320-7326.
96. Esteller M., Garcia-Foncillas J., Andion E., Goodman S.N., Hidalgo O.F., Vanaclocha V., Baylin S.B., Herman J.G. Inactivation of the DNA-repair gene MGMT and the clinical response of gliomas to alkylating agents. N. Engl. J. Med. 2000, 343:1350-1354.
97. Magewu A.N., Jones P.A. Ubiquitous and tenacious methylation of the CpG site in codon 248 of the p53 gene may explain its frequent appearance as a mutational hot spot in human cancer. Mol. Cell. Biol. 1994, 14:4225-4232.
98. Zou H.Z., Yu B.M., Wang Z.W., Sun J.Y., Cang H., Gao F., Li D.H., Zhao R., Feng G.G., Yi J. Detection of aberrant p16 methylation in the serum of colorectal cancer patients. Clin. Cancer Res. 2002, 8:188-191.
99. Mayor R., Casadome L., Azuara D., Moreno V., Clark S.J., Capella G., Peinado M.A. Long-range epigenetic silencing at 2q14.2 affects most human colorectal cancers and may have application as a non-invasive biomarker of disease. Br. J. Cancer 2009, 100:1534-1539.
100. Esteller M., Gonzalez S., Risques R.A., Marcuello E., Mangues R., Germa J.R., Herman J.G., Capella G., Peinado M.A. K-ras and p16 aberrations confer poor prognosis in human colorectal cancer. J. Clin. Oncol. 2001, 19:299-304.
101. Lecomte T., Berger A., Zinzindohoue F., Micard S., Landi B., Blons H., Beaune P., Cugnenc P.H., Laurent-Puig P. Detection of free-circulating tumor-associated DNA in plasma of colorectal cancer patients and its association with prognosis. Int. J. Cancer 2002, 100:542-548.
102. Umetani N., Takeuchi H., Fujimoto A., Shinozaki M., Bilchik A.J., Hoon D.S. Epigenetic inactivation of ID4 in colorectal carcinomas correlates with poor differentiation and unfavorable prognosis. Clin. Cancer Res. 2004, 10:7475-7483.
103. Shen L., Toyota M., Kondo Y., Lin E., Zhang L., Guo Y., Hernandez N.S., Chen X., Ahmed S., Konishi K., Hamilton S.R., Issa J.P. Integrated genetic and epigenetic analysis identifies three different subclasses of colon cancer. Proc. Natl. Acad. Sci. U. S. A. 2007, 104:18654-18659.
104. Esteller M., Tortola S., Toyota M., Capella G., Peinado M.A., Baylin S.B., Herman J.G. Hypermethylation-associated inactivation of p14(ARF) is independent of p16(INK4a) methylation and p53 mutational status. Cancer Res. 2000, 60:129-133.
105. Ide T., Kitajima Y., Ohtaka K., Mitsuno M., Nakafusa Y., Miyazaki K. Expression of the hMLH1 gene is a possible predictor for the clinical response to 5-fluorouracil after a surgical resection in colorectal cancer. Oncol. Rep. 2008, 19:1571-1576.
106. Chaney S.G., Sancar A. DNA repair: enzymatic mechanisms and relevance to drug response. J. Natl. Cancer Inst. 1996, 88:1346-1360.
107. Kawate H., Itoh R., Sakumi K., Nakabeppu Y., Tsuzuki T., Ide F., Ishikawa T., Noda T., Nawata H., Sekiguchi M. A defect in a single allele of the Mlh1 gene causes dissociation of the killing and tumorigenic actions of an alkylating carcinogen in methyltransferase-deficient mice. Carcinogenesis 2000, 21:301-305.
108. Toyota M., Shen L., Ohe-Toyota M., Hamilton S.R., Sinicrope F.A., Issa J.P. Aberrant methylation of the cyclooxygenase 2 CpG island in colorectal tumors. Cancer Res. 2000, 60:4044-4048.
109. Steinbach G., Lynch P.M., Phillips R.K., Wallace M.H., Hawk E., Gordon G.B., Wakabayashi N., Saunders B., Shen Y., Fujimura T., Su L.K., Levin B. The effect of celecoxib, a cyclooxygenase-2 inhibitor, in familial adenomatous polyposis. N. Engl. J. Med. 2000, 342:1946-1952.
110. Gonzalgo M.L, Jones P.A. Quantitative methylation analysis using methylation-sensitive single-nucleotide primer extension (Ms-SNuPE). Methods 2002, 27:128-133.
111. Bianco T., Hussey D., Dobrovic A. Methylation-sensitive, single-strand conformation analysis (MS-SSCA): a rapid method to screen for and analyze methylation. Hum. Mutat. 1999, 14:289-293.
112. Gonzalgo M.L, Liang G., Spruck C.H., Zingg J.M., Rideout W.M., Jones P.A. Identification and characterization of differentially methylated regions of genomic DNA by methylation-sensitive arbitrarily primed PCR. Cancer Res. 1997, 57:594-599.
113. Rodriguez J., Muñoz M., Vives L., Frangou C.G., Groudine M., Peinado M.A. Bivalent domains enforce transcriptional memory of DNA methylated genes in cancer cells. Proc. Natl. Acad. Sci. U. S. A. 2008, 105:19809-19814.
114. Li H., Myeroff L., Smiraglia D., Romero M.F., Pretlow T.P., Kasturi L., Lutterbaugh J., Rerko R.M., Casey G., Issa J.P., Willis J., Willson J.K., Plass C., Markowitz S.D. SLC5A8, a sodium transporter, is a tumor suppressor gene silenced by methylation in human colon aberrant crypt foci and cancers. Proc. Natl. Acad. Sci. U. S. A. 2003, 100:8412-8417.
115. Liang G., Robertson K.D., Talmadge C., Sumegi J., Jones P.A. The gene for a novel transmembrane protein containing epidermal growth factor and follistatin domains is frequently hypermethylated in human tumor cells. Cancer Res. 2000, 60:4907-4912.